Shah, Vallari
,
Sherborne, Amy L. http://orcid.org/0000-0002-9717-4773
Johnson, David C.
Ellis, Sidra
Price, Amy
Chowdhury, Farzana
Kendall, Jack
Jenner, Matthew W.
Drayson, Mark T.
Owen, Roger G.
Gregory, Walter M.
Morgan, Gareth J.
Davies, Faith E.
Cook, Gordon http://orcid.org/0000-0003-1717-0412
Cairns, David A. http://orcid.org/0000-0002-2338-0179
Houlston, Richard S. http://orcid.org/0000-0002-5268-0242
Jackson, Graham
Kaiser, Martin F. http://orcid.org/0000-0002-3677-4804
Funding for this research was provided by:
DH | National Institute for Health Research (RMH/ICR BRC A107)
Myeloma UK (Program grant)
Article History
Received: 11 October 2019
Revised: 4 February 2020
Accepted: 6 February 2020
First Online: 11 March 2020
Compliance with ethical standards
:
: VS: Sanofi—travel support; Janssen—travel support. MTD: Abingdon Health—equity ownership, membership on board of directors. RGO Takeda—honoraria, travel support; Janssen—consultancy, travel support; Celgene Corporation—consultancy, honoraria, research funding. FED Amgen—consultancy, honoraria; AbbVie—consultancy, honoraria; Takeda—consultancy, honoraria; Janssen—consultancy, honoraria; Celgene Corporation—consultancy, honoraria. GJM: Janssen—research funding; Bristol-Myers Squibb—consultancy, honoraria; Takeda—consultancy, honoraria; Celgene Corporation—consultancy, honoraria, research funding. DAC: Celgene Corporation, Amgen, Merck Sharp and Dohme—research funding. GC: Takeda—consultancy, honoraria, research funding, speakers bureau; Glycomimetics—consultancy, honoraria; Sanofi—consultancy, honoraria, speakers bureau; Celgene Corporation—consultancy, honoraria, research funding, speakers bureau; Janssen—consultancy, honoraria, research funding, speakers bureau; Bristol-Myers Squibb—consultancy, honoraria; Amgen—consultancy, honoraria, research funding, speakers bureau. GJ Roche—consultancy, honoraria, speakers bureau; Amgen—consultancy, honoraria, speakers bureau; Janssen—consultancy, honoraria, speakers bureau; Merck Sharp and Dohme—consultancy, honoraria, speakers bureau; Celgene Corporation—consultancy, honoraria, travel support, research funding, speakers bureau; Takeda—consultancy, honoraria, travel support, research funding, speakers bureau. MFK Bristol-Myers Squibb—consultancy, travel support; Chugai—consultancy; Janssen—consultancy, honoraria; Amgen—consultancy, honoraria; Takeda—consultancy, travel support; Celgene Corporation—consultancy, honoraria, research funding. The remaining authors declare no conflict of interest.